EPiQ Life Science AB

EPiQ Life Science AB develops innovative solutions for the diagnosis and treatment of atrial fibrillation, and coronary disease, that dramatically shortens procedure time, reduces cost and increases the quality of care. Electrophysiologists and interventional cardiologists can better manage the increased demands for efficiency and cost reduction that care givers across the globe are challenged with as a consequence of the aging population in the world.